Wells Fargo’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3K | Sell |
|
|||||
|
2025
Q1 | $51.2K | Buy |
|
|||||
|
2024
Q4 | $47.7K | Buy |
|
|||||
|
2024
Q3 | $64.6K | Buy |
|
|||||
|
2024
Q2 | $67.3K | Buy |
|
|||||
|
2024
Q1 | $89.4K | Sell |
|
|||||
|
2023
Q4 | $66.4K | Buy |
|
|||||
|
2023
Q3 | $61.6K | Sell |
|
|||||
|
2023
Q2 | $113K | Buy |
|
|||||
|
2023
Q1 | $40.3K | Sell |
|
|||||
|
2022
Q4 | $31.5K | Buy |
|
|||||
|
2022
Q3 | $6K | Sell |
|
|||||
|
2022
Q2 | $13K | Sell |
|
|||||
|
2022
Q1 | $312K | Sell |
|
|||||
|
2021
Q4 | $1.29M | Sell |
|
|||||
|
2021
Q3 | $1.78M | Buy |
|
|||||
|
2021
Q2 | $30K | Buy |
|
|||||
|
2021
Q1 | $22K | Sell |
|
|||||
|
2020
Q4 | $231K | Buy |
|
|||||
|
2020
Q3 | $121K | Sell |
|
|||||
|
2020
Q2 | $135K | Sell |
|
|||||
|
2020
Q1 | $249K | Buy |
|
|||||
|
2019
Q4 | $162K | Buy |
|
|||||
|
2019
Q3 | $50K | Buy |
|
|||||
|
2019
Q2 | $52K | Sell |
|
|||||
|
2019
Q1 | $73K | Sell |
|
|||||
|
2018
Q4 | $55K | Sell |
|
|||||
|
2018
Q3 | $130K | Buy |
|
|||||
|
2018
Q2 | $106K | Sell |
|
|||||
|
2018
Q1 | $380K | Buy |
|
|||||
|
2017
Q4 | $298K | Buy |
|
|||||
|
2017
Q3 | $304K | Buy |
|
|||||
|
2017
Q2 | $243K | Buy |
|
|||||
|
2017
Q1 | $260K | Sell |
|
|||||
|
2016
Q4 | $277K | Buy |
|
|||||
|
2016
Q3 | $206K | Buy |
|
|||||
|
2016
Q2 | $61K | Sell |
|
|||||
|
2016
Q1 | $93K | Sell |
|
|||||
|
2015
Q4 | $149K | Sell |
|
|||||
|
2015
Q3 | $112K | Buy |
|
|||||
|
2015
Q2 | $96K | Buy |
|
|||||
|
2015
Q1 | $31K | Buy |
|
|||||
|
2014
Q4 | $16K | Sell |
|
|||||
|
2014
Q3 | $22K | Sell |
|
|||||
|
2014
Q2 | $27K | Buy |
|
|||||
|
2014
Q1 | $12K | Sell |
|
|||||
|
2013
Q4 | $15K | Buy |
|
|||||
|
2013
Q3 | $15K | Hold |
|
|||||
|
2013
Q2 | $16K | Buy |
|